Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Barbour Named To HOPA Board of Directors

Sally Yowell Barbour, PharmD, BCOP, CPP, FHOPA, director of Oncology Pharmacy Programs and clinical oncology pharmacist at Duke Cancer Institute, was recently appointed to the Hematology/Oncology Pharmacy Association ( HOPA ) Board of Directors where she serves at secretary. “I am honored and...

Strike Out For Sarcoma

Step out on Sunday, Sept. 9, for the 9th Annual Strike Out For Sarcoma 5K and Family Run . The event, hosted by Duke Multidisciplinary Sarcoma Program, takes place WakeMed Soccer Field in Cary, North Carolina. According to the American Cancer Society a sarcoma is a type of cancer that develops from...

Clarke To Lead Team DCI At 2018 LUNGe Forward 5K

The Lung Cancer Inititative of North Carolina will host its 12th annual LUNGe Forward 5K on Sunday, Sept. 23, at 12:30 p.m. at Midtown Park at North Hills Mall in Raleigh, North Carolina. Team Duke Cancer Institute will be led this year by Jeffrey Clarke , MD, a medical oncologist specializing in...

Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors

Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified. Now scientists at Duke Cancer Institute have identified mutations for the vast majority of the remaining 20 percent of...

Tests Identify When Advanced Prostate Cancer Therapies Would Benefit

Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute. The blood tests, dubbed “liquid biopsies”, detect...

LeBlanc And Abernethy Patient-Care Paper Recognized

A journal article by hematologic oncologist, palliative care physician, and associate professor of medicine Thomas LeBlanc, MD , and adjunct professor of medicine Amy Abernethy, MD, PhD , has been recognized as a paper that could " Change the World, One Article At A Time " by Springer Nature...

Analysis: Survival Benefit for African-Americans with Advanced Prostate Cancer

Contrary to current perceptions, certain African-American men with advanced prostate cancer have as good a chance of survival as white men and might actually have a small advantage, according to a new analysis of more than 8,000 patients who participated in clinical trials. In a study presented...

Black Patients Show Stronger Response to Hormone Therapy for Prostate Cancer

African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers. While median survival was similar for both black and white participants in the study, the findings...

Wei Receives $200,000 Grant For Lung Cancer Research

In partnership, Lung Cancer Initiative of North Carolina and The V Foundation for Cancer Research have awarded a $200,000 grant to Qingyi Wei , MD, PhD, Duke Cancer Institute. The grant funds research on disparities among African-Americans, with a focus on lung cancer patients in North Carolina...

Legislation Will Help Kids With Cancer Live Longer, Healthier Lives

The American Association for Cancer Research (AACR) is commending Congress for working in a bipartisan fashion to pass the Childhood Cancer Survivorship, Treatment, Access & Research (STAR) Act of 2018. The STAR Act passed in the House of Representatives yesterday after having passed in the...

Ophthalmic Oncology Center Expands Multidisciplinary Services

To meet growing demand, Duke University Eye Center now offers a vast, full-service Ophthalmic Oncology Center that provides a comprehensive approach to diagnosis and treatment for tumors in and around the eye. The Duke Ophthalmic Oncology Center provides the latest care and treatment for primary...

Myeloma Specialist To Pedal Across England And France

Cristina Gasparetto , MD, hematologic malignancies and cellular therapy specialist, has signed on to participate in the road to Victories London to Paris Ride, a challenge event supporting the Multiple Myeloma Research Foundation’s (MMRF) mission to fund myeloma research leading to better...

Pages